Alirocumab prevents atrial fibrillation in hypertension and obese mice through alleviation of PCSK9 induced atrial remodeling by regulating arachidonic acid metabolism
30 August 2025 (12:30 - 13:15)
Organised by: 
About the speaker
Shanghai Sixth People's Hospital, Shanghai (China)
8 More presentations in this session
Access the full session
The Event
ESC Congress 2025
30 August 2025
12:30 CET
You may be interested in
Congress Session
Congress Presentation
